Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
PZ Wind Down Inc | 10.0 | 0.0x | --- |
Regnum Corp | 20.0 | 0.0x | --- |
FluoroPharma Medical Inc | 3.4K | 0.0x | --- |
Life Stem Genetics Inc | 24.6K | 0.0x | --- |
FutureWorld Corp | 5.2K | 0.0x | --- |
Poniard Pharmaceuticals Inc | 150.0 | 0.0x | --- |
Pz Wind Down, Inc., formerly, PhaseRx, Inc. is a biopharmaceutical company developing a portfolio of mRNA products to correct life-threatening inherited liver diseases in children. The Company's initial product development focus is on urea cycle disorders, a group of rare genetic diseases that generally present before the age of 12 and are characterized by the body's inability to remove ammonia from the blood. The Company's i-ERT approach is enabled by its Hybrid mRNA Technology platform and is applicable to a number of inherited liver diseases. The Company is headquartered in Seattle.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $10.00 |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 11.7M |
PZ Wind Down Inc does not pay a dividend. | |
Beta | --- |
EPS | $-1.19 |
Book Value | $0.80 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.